Synergistic drug combinations tend to improve therapeutically relevant selectivity

Joseph Lehár(BioFormatix (United States)), Andrew Krueger(Boston University), William Avery(BioFormatix (United States)), Adrian Heilbut(BioFormatix (United States)), Lisa M. Johansen(BioFormatix (United States)), Edward Price(BioFormatix (United States)), Richard J. Rickles(BioFormatix (United States)), Glenn F. Short(BioFormatix (United States)), Jane Staunton(BioFormatix (United States)), Xiaowei Jin(BioFormatix (United States)), Margaret Lee(BioFormatix (United States)), Grant R. Zimmermann(BioFormatix (United States)), Alexis A. Borisy(BioFormatix (United States))
Nature Biotechnology
July 1, 2009
10.1038/nbt.1549
Cited by 954Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis